Philippines animal vaccines market to reach $537.31 million by 2034

By AI, Created 6:45 AM UTC, May 20, 2026, /AGP/ – The Philippines animal vaccines market reached $304.62 million in 2025 and is projected to grow to $537.31 million by 2034, driven by government disease-control programs, rising livestock production and growing pet-care demand. The market is being reshaped by African swine fever vaccination efforts, new domestic vaccine R&D capacity and expanding biosafety requirements across farms.

Why it matters: - The Philippines animal vaccines market is moving from outbreak response to longer-term disease prevention. - Growth matters for pork and poultry supply stability, farm productivity and companion-animal health. - Government vaccination programs are also helping reduce disease pressure across the country’s swine herd.

What happened: - The market reached $304.62 million in 2025 and is projected to hit $537.31 million by 2034. - The forecast implies a 6.51% compound annual growth rate from 2026 to 2034. - The Department of Agriculture inaugurated the vaccine unit at the Center for Transboundary Animal Diseases in April 2025. - The facility is based at Central Luzon State University in Nueva Ecija. - The government allocated PHP 151 million for a three-year vaccine development program. - The program targets vaccines for African swine fever, avian influenza and foot-and-mouth disease. - The Bureau of Animal Industry reported a 92% decline in ASF-affected barangays in January 2026, from 98 in late December 2025 to 8 by mid-January 2026. - Nearly 500,000 pigs have been vaccinated under the government-regulated ASF vaccination program. - Healthy animals in the program recorded a 90% efficacy rate.

The details: - Attenuated vaccines hold the largest product share, supported by strong immune responses in poultry, swine and cattle. - Livestock animals are the largest animal-type segment because of the country’s commercial poultry and swine industries. - Intramuscular administration leads the route-of-administration segment because it supports reliable delivery and consistent immune response. - Companion animal vaccines are the fastest-growing segment as pet adoption rises in urban households. - Rabies prevention is a major driver of companion-animal vaccine demand. - Recombinant and DNA vaccines are gaining attention for improved safety, stronger immunogenicity and the ability to distinguish vaccinated animals from naturally infected ones. - The swine segment is seeing stronger vaccine demand after ASF outbreaks that began in 2019. - Luzon holds the largest regional share, supported by dense poultry and swine farming, major distributors, cold chain infrastructure and proximity to veterinary research institutions. - Government disease-control efforts include emergency vaccine procurement, disease monitoring systems and zonation-based deployment. - Free vaccination campaigns for rabies and other zoonotic diseases are expanding coverage across livestock and companion animals. - Commercial poultry and swine farms are expanding, and backyard farms are becoming more commercialized. - The report says pork production is expected to recover in 2026, supported by wider ASF vaccine coverage, stronger biosecurity and improved swine genetics. - Urban pet ownership trends are increasing demand for vaccines for dogs and cats. - Veterinary clinic and diagnostic-laboratory expansion is improving access to vaccination services. - Cold chain modernization is improving vaccine distribution across the archipelago.

Between the lines: - The market’s growth is being driven by both crisis response and structural change. - ASF is still a central risk, but vaccination is beginning to reduce the scale of outbreaks. - Domestic R&D capacity suggests a gradual shift away from import dependence. - International vaccine makers still dominate advanced supply, but local production could change pricing and access over time. - Demand is broadening beyond livestock as pet care becomes more preventive and routine.

What’s next: - More coverage is likely as ASF vaccination programs expand across commercial and backyard swine operations. - The Center for Transboundary Animal Diseases is expected to advance local development of ASF, avian influenza and FMD vaccines. - Manufacturers are likely to keep pushing multivalent and next-generation products. - Continued cold chain investment should improve reach in remote provinces and island communities. - Companion-animal vaccination demand should keep rising during recurring rabies awareness campaigns.

The bottom line: - The Philippines animal vaccines market is becoming a government-backed growth market with room for both livestock recovery and companion-animal expansion. - More information